Management of multiorgan failure caused by immune checkpoint inhibitor toxicity
Sign Up to like & getrecommendations! Published in 2025 at "BMJ Case Reports"
DOI: 10.1136/bcr-2024-262209
Abstract: Immune checkpoint inhibitors (ICIs) block inhibitory pathways that tumour cells exploit to evade the immune system. They play a key role in the management of aggressive cancers, including non-small cell lung cancer, melanoma and Hodgkin’s… read more here.
Keywords: multiorgan failure; immune checkpoint; failure; management multiorgan ... See more keywords